United States Biotechnology & Medical Research

Array BioPharma Inc (ARRY)

Track

Track

Ticker: ARRY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.8
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
324.03
Quantity 12,622 -42.9%
Value US$3,066,714
0.8
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
422.15
Quantity 63,705 +35.9%
Value US$1,037,954
0.8
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
161.00
Quantity 98,693 +30.3%
Value US$447,291
0.8
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
27.00
Quantity 74,915 -26.3%
Value US$2,022,930
0.8
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
26.50
Quantity 40,634 -14.6%
Value US$1,076,846
0.8
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
26.50
Quantity 12,600 -5.0%
Value US$333,900
2.8
COX CARRIE SMITH
Transaction date
Purchase
Price
23.20
Quantity 5,000 +166.7%
Value US$115,998
Haddock Jason CFO
Transaction date
Planned sale
Price
22.05
Quantity 85,000 -73.9%
Value US$1,874,301
0.8
Squarer Ron CEO
Transaction date
Planned sale
Price
21.64
Quantity 110,000 -31.5%
Value US$2,380,015
3.6
Saccomano Nicholas A CSO
Transaction date
Planned sale
Price
21.58
Quantity 187,264 -56.8%
Value US$4,041,756
Haddock Jason CFO
Transaction date
Planned sale
Price
20.00
Quantity 11,712 -28.0%
Value US$234,240
LEFKOFF KYLE
Transaction date
Sale
Price
20.85
Quantity 5,000 -20.0%
Value US$104,261
LEFKOFF KYLE
Transaction date
Sale
Price
20.82
Quantity 5,000 -16.7%
Value US$104,120
LEFKOFF KYLE
Transaction date
Sale
Price
20.51
Quantity 25,000 -52.4%
Value US$512,692
Robbins Andrew R COO
Transaction date
Sale
Price
20.03
Quantity 239,626 -80.0%
Value US$4,798,511
2.5
Oltmans Curtis Gale General Counsel
Transaction date
Planned sale
Price
20.00
Quantity 40,000 -72.7%
Value US$800,000
0.8
Squarer Ron CEO
Transaction date
Planned sale
Price
18.53
Quantity 113,438 -32.2%
Value US$2,101,541
0.8
Squarer Ron CEO
Transaction date
Planned sale
Price
18.25
Quantity 100,000 -29.5%
Value US$1,825,370
2.5
Oltmans Curtis Gale General Counsel
Transaction date
Planned sale
Price
18.00
Quantity 14,029 -78.2%
Value US$252,523
2.5
Oltmans Curtis Gale General Counsel
Transaction date
Planned sale
Price
18.00
Quantity 1,251 -24.2%
Value US$22,518
2.5
Oltmans Curtis Gale General Counsel
Transaction date
Planned sale
Price
18.06
Quantity 19,720 -83.4%
Value US$356,139
0.8
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
14.05
Quantity 6,268 -2.7%
Value US$88,091
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
16.21
Quantity 115,185 -34.1%
Value US$1,867,045
COX CARRIE SMITH
Transaction date
Purchase
Price
16.87
Quantity 3,000 +inf%
Value US$50,595
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
14.76
Quantity 18,000 -48.3%
Value US$265,684
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
15.38
Quantity 9,687 -4.4%
Value US$148,938
Haddock Jason CFO
Transaction date
Planned sale
Price
13.92
Quantity 20,000 -36.1%
Value US$278,400
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
13.92
Quantity 21,500 -52.7%
Value US$299,280
Haddock Jason CFO
Transaction date
Planned sale
Price
14.87
Quantity 25,000 -31.1%
Value US$371,750
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
16.56
Quantity 21,500 -52.7%
Value US$356,040
LEFKOFF KYLE Non-Executive Director
Transaction date
Sale
Price
17.45
Quantity 50,000 -73.8%
Value US$872,500
Robbins Andrew R COO
Transaction date
Planned sale
Price
17.74
Quantity 17,964 -10.1%
Value US$318,681
Squarer Ron CEO
Transaction date
Planned sale
Price
18.03
Quantity 140,625 -39.9%
Value US$2,535,469
Squarer Ron CEO
Transaction date
Planned sale
Price
17.74
Quantity 43,628 -17.1%
Value US$773,961
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
19.08
Quantity 21,500 -52.7%
Value US$410,220
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
18.76
Quantity 77,576 -27.0%
Value US$1,455,326
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
18.75
Quantity 22,424 -9.6%
Value US$420,450
VAN LUNSEN GIL J Non-Executive Director
Transaction date
Planned sale
Price
15.36
Quantity 21,500 -52.7%
Value US$330,259
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
15.19
Quantity 21,500 -52.7%
Value US$326,585
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
15.35
Quantity 8,689 -4.0%
Value US$133,376
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
16.76
Quantity 21,500 -52.7%
Value US$360,340
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
17.72
Quantity 111,518 -33.9%
Value US$1,976,099
Sandor Victor Chief Medical Officer
Transaction date
Planned sale
Price
17.70
Quantity 44,498 -11.9%
Value US$787,615
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
17.16
Quantity 21,500 -52.7%
Value US$368,940
BAUM CHARLES M
Transaction date
Sale
Price
16.90
Quantity 50,000 -83.3%
Value US$845,000
LEFKOFF KYLE
Transaction date
Sale
Price
17.01
Quantity 50,000 -73.8%
Value US$850,500
VAN LUNSEN GIL J
Transaction date
Planned sale
Price
12.94
Quantity 21,500 -52.7%
Value US$278,210
Haddock Jason CFO
Transaction date
Planned sale
Price
13.73
Quantity 7,500 -20.6%
Value US$102,975
Squarer Ron CEO
Transaction date
Planned sale
Price
10.93
Quantity 546,233 -72.3%
Value US$5,970,327
Squarer Ron CEO
Transaction date
Planned sale
Price
10.73
Quantity 273,438 -56.6%
Value US$2,933,990
Robbins Andrew R COO
Transaction date
Planned sale
Price
10.72
Quantity 282,874 -64.1%
Value US$3,032,409
LEFKOFF KYLE
Transaction date
Sale
Price
12.31
Quantity 38,865 -75.3%
Value US$478,428
VAN LUNSEN GIL J
Transaction date
Sale
Price
12.36
Quantity 39,928 -72.3%
Value US$493,510
LEFKOFF KYLE
Transaction date
Sale
Price
8.92
Quantity 45,000 -87.2%
Value US$401,400
BAUM CHARLES M
Transaction date
Sale
Price
9.27
Quantity 25,000 -83.3%
Value US$231,750
Redmile Group, LLC Large shareholder
Transaction date
Sale
Price
6.36
Quantity 2,492,578 -13.0%
Value US$15,852,796
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 28,000 +0.1%
Value US$98,000
Redmile Group, LLC Large shareholder
Transaction date
Sale
Price
3.54
Quantity 7,300 -0.0%
Value US$25,842
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
3.51
Quantity 372,000 +2.0%
Value US$1,305,720
Redmile Group, LLC Large shareholder
Transaction date
Sale
Price
3.50
Quantity 392,700 -2.1%
Value US$1,374,450
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
3.19
Quantity 300,000 +1.6%
Value US$957,000
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
3.60
Quantity 75,000 +0.4%
Value US$270,000
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
3.54
Quantity 275,000 +1.5%
Value US$973,500
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
3.72
Quantity 350,000 +1.9%
Value US$1,302,000
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
3.73
Quantity 300,000 +1.7%
Value US$1,119,000
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
4.50
Quantity 100,140 +0.6%
Value US$450,630
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
4.67
Quantity 182,452 +1.0%
Value US$852,051
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
4.56
Quantity 500,000 +2.9%
Value US$2,280,000
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
5.48
Quantity 49,900 +0.3%
Value US$273,452
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
5.45
Quantity 220,000 +1.3%
Value US$1,199,000
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
5.32
Quantity 410,000 +2.5%
Value US$2,181,200
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
5.45
Quantity 160,000 +1.0%
Value US$872,000
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
5.93
Quantity 205,000 +1.3%
Value US$1,215,650
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
5.85
Quantity 327,500 +2.1%
Value US$1,915,875
Redmile Group, LLC Large shareholder
Transaction date
Purchase
Price
5.81
Quantity 180,000 +1.1%
Value US$1,045,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-06-06 2019-06-04 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
12,622 -42.9%
324.03
US$3,066,714 		12,622 -42.9% 324.03 US$3,066,714
2019-06-03 2019-06-03 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
63,705 +35.9%
422.15
US$1,037,954 		63,705 +35.9% 422.15 US$1,037,954
2019-06-03 2019-05-30 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
98,693 +30.3%
161.00
US$447,291 		98,693 +30.3% 161.00 US$447,291
2019-05-28 2019-05-28 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
74,915 -26.3%
27.00
US$2,022,930 		74,915 -26.3% 27.00 US$2,022,930
2019-05-28 2019-05-23 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
40,634 -14.6%
26.50
US$1,076,846 		40,634 -14.6% 26.50 US$1,076,846
2019-05-23 2019-05-21 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
12,600 -5.0%
26.50
US$333,900 		12,600 -5.0% 26.50 US$333,900
2019-02-21 2019-02-19 B Purchase
2.8
COX CARRIE SMITH
5,000 +166.7%
23.20
US$115,998 		5,000 +166.7% 23.20 US$115,998
2019-02-08 2019-02-07 PlS Planned sale
Haddock Jason

CFO
85,000 -73.9%
22.05
US$1,874,301 		85,000 -73.9% 22.05 US$1,874,301
2019-02-08 2019-02-07 PlS Planned sale
0.8
Squarer Ron

CEO
110,000 -31.5%
21.64
US$2,380,015 		110,000 -31.5% 21.64 US$2,380,015
2019-02-08 2019-02-07 PlS Planned sale
3.6
Saccomano Nicholas A

CSO
187,264 -56.8%
21.58
US$4,041,756 		187,264 -56.8% 21.58 US$4,041,756
2019-02-08 2019-02-06 PlS Planned sale
Haddock Jason

CFO
11,712 -28.0%
20.00
US$234,240 		11,712 -28.0% 20.00 US$234,240
2019-02-08 2019-02-06 S Sale
LEFKOFF KYLE
5,000 -20.0%
20.85
US$104,261 		5,000 -20.0% 20.85 US$104,261
2019-02-08 2019-02-06 S Sale
LEFKOFF KYLE
5,000 -16.7%
20.82
US$104,120 		5,000 -16.7% 20.82 US$104,120
2019-02-08 2019-02-06 S Sale
LEFKOFF KYLE
25,000 -52.4%
20.51
US$512,692 		25,000 -52.4% 20.51 US$512,692
2019-02-08 2019-02-06 S Sale
Robbins Andrew R

COO
239,626 -80.0%
20.03
US$4,798,511 		239,626 -80.0% 20.03 US$4,798,511
2019-02-07 2019-02-05 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
40,000 -72.7%
20.00
US$800,000 		40,000 -72.7% 20.00 US$800,000
2019-02-01 2019-01-31 PlS Planned sale
0.8
Squarer Ron

CEO
113,438 -32.2%
18.53
US$2,101,541 		113,438 -32.2% 18.53 US$2,101,541
2019-02-01 2019-01-30 PlS Planned sale
0.8
Squarer Ron

CEO
100,000 -29.5%
18.25
US$1,825,370 		100,000 -29.5% 18.25 US$1,825,370
2019-01-29 2019-01-25 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
14,029 -78.2%
18.00
US$252,523 		14,029 -78.2% 18.00 US$252,523
2019-01-23 2019-01-18 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
1,251 -24.2%
18.00
US$22,518 		1,251 -24.2% 18.00 US$22,518
2019-01-17 2019-01-15 PlS Planned sale
2.5
Oltmans Curtis Gale

General Counsel
19,720 -83.4%
18.06
US$356,139 		19,720 -83.4% 18.06 US$356,139
2019-01-02 2018-12-27 PlS Planned sale
0.8
Sandor Victor

Chief Medical Officer
6,268 -2.7%
14.05
US$88,091 		6,268 -2.7% 14.05 US$88,091
2018-12-06 2018-12-03 PlS Planned sale Sandor Victor

Chief Medical Officer
115,185 -34.1%
16.21
US$1,867,045 		115,185 -34.1% 16.21 US$1,867,045
2018-11-05 2018-11-01 B Purchase COX CARRIE SMITH
3,000 +inf%
16.87
US$50,595 		3,000 +inf% 16.87 US$50,595
2018-09-21 2018-09-19 PlS Planned sale VAN LUNSEN GIL J
18,000 -48.3%
14.76
US$265,684 		18,000 -48.3% 14.76 US$265,684
2018-09-05 2018-09-04 PlS Planned sale Sandor Victor

Chief Medical Officer
9,687 -4.4%
15.38
US$148,938 		9,687 -4.4% 15.38 US$148,938
2018-08-17 2018-08-15 PlS Planned sale Haddock Jason

CFO
20,000 -36.1%
13.92
US$278,400 		20,000 -36.1% 13.92 US$278,400
2018-08-17 2018-08-15 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
13.92
US$299,280 		21,500 -52.7% 13.92 US$299,280
2018-07-31 2018-07-30 PlS Planned sale Haddock Jason

CFO
25,000 -31.1%
14.87
US$371,750 		25,000 -31.1% 14.87 US$371,750
2018-07-19 2018-07-18 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
16.56
US$356,040 		21,500 -52.7% 16.56 US$356,040
2018-07-06 2018-07-06 S Sale LEFKOFF KYLE Non-Executive Director
50,000 -73.8%
17.45
US$872,500 		50,000 -73.8% 17.45 US$872,500
2018-06-29 2018-06-27 PlS Planned sale Robbins Andrew R

COO
17,964 -10.1%
17.74
US$318,681 		17,964 -10.1% 17.74 US$318,681
2018-06-29 2018-06-27 PlS Planned sale Squarer Ron

CEO
140,625 -39.9%
18.03
US$2,535,469 		140,625 -39.9% 18.03 US$2,535,469
2018-06-29 2018-06-27 PlS Planned sale Squarer Ron

CEO
43,628 -17.1%
17.74
US$773,961 		43,628 -17.1% 17.74 US$773,961
2018-06-21 2018-06-20 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
19.08
US$410,220 		21,500 -52.7% 19.08 US$410,220
2018-06-21 2018-06-19 PlS Planned sale Sandor Victor

Chief Medical Officer
77,576 -27.0%
18.76
US$1,455,326 		77,576 -27.0% 18.76 US$1,455,326
2018-06-15 2018-06-13 PlS Planned sale Sandor Victor

Chief Medical Officer
22,424 -9.6%
18.75
US$420,450 		22,424 -9.6% 18.75 US$420,450
2018-05-17 2018-05-16 PlS Planned sale VAN LUNSEN GIL J Non-Executive Director
21,500 -52.7%
15.36
US$330,259 		21,500 -52.7% 15.36 US$330,259
2018-04-18 2018-04-18 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
15.19
US$326,585 		21,500 -52.7% 15.19 US$326,585
2018-04-03 2018-04-03 PlS Planned sale Sandor Victor

Chief Medical Officer
8,689 -4.0%
15.35
US$133,376 		8,689 -4.0% 15.35 US$133,376
2018-03-21 2018-03-21 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
16.76
US$360,340 		21,500 -52.7% 16.76 US$360,340
2018-03-09 2018-03-09 PlS Planned sale Sandor Victor

Chief Medical Officer
111,518 -33.9%
17.72
US$1,976,099 		111,518 -33.9% 17.72 US$1,976,099
2018-03-09 2018-03-09 PlS Planned sale Sandor Victor

Chief Medical Officer
44,498 -11.9%
17.70
US$787,615 		44,498 -11.9% 17.70 US$787,615
2018-02-23 2018-02-21 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
17.16
US$368,940 		21,500 -52.7% 17.16 US$368,940
2018-02-12 2018-02-09 S Sale BAUM CHARLES M
50,000 -83.3%
16.90
US$845,000 		50,000 -83.3% 16.90 US$845,000
2018-02-12 2018-02-09 S Sale LEFKOFF KYLE
50,000 -73.8%
17.01
US$850,500 		50,000 -73.8% 17.01 US$850,500
2018-01-17 2018-01-17 PlS Planned sale VAN LUNSEN GIL J
21,500 -52.7%
12.94
US$278,210 		21,500 -52.7% 12.94 US$278,210
2018-01-16 2018-01-16 PlS Planned sale Haddock Jason

CFO
7,500 -20.6%
13.73
US$102,975 		7,500 -20.6% 13.73 US$102,975
2017-12-19 2017-12-19 PlS Planned sale Squarer Ron

CEO
546,233 -72.3%
10.93
US$5,970,327 		546,233 -72.3% 10.93 US$5,970,327
2017-12-19 2017-12-18 PlS Planned sale Squarer Ron

CEO
273,438 -56.6%
10.73
US$2,933,990 		273,438 -56.6% 10.73 US$2,933,990
2017-12-19 2017-12-18 PlS Planned sale Robbins Andrew R

COO
282,874 -64.1%
10.72
US$3,032,409 		282,874 -64.1% 10.72 US$3,032,409
2017-09-29 2017-09-29 S Sale LEFKOFF KYLE
38,865 -75.3%
12.31
US$478,428 		38,865 -75.3% 12.31 US$478,428
2017-09-29 2017-09-29 S Sale VAN LUNSEN GIL J
39,928 -72.3%
12.36
US$493,510 		39,928 -72.3% 12.36 US$493,510
2017-04-04 2017-03-31 S Sale LEFKOFF KYLE
45,000 -87.2%
8.92
US$401,400 		45,000 -87.2% 8.92 US$401,400
2017-03-30 2017-03-28 S Sale BAUM CHARLES M
25,000 -83.3%
9.27
US$231,750 		25,000 -83.3% 9.27 US$231,750
2016-09-30 2016-09-28 S Sale Redmile Group, LLC Large shareholder
2,492,578 -13.0%
6.36
US$15,852,796 		2,492,578 -13.0% 6.36 US$15,852,796
2016-09-16 2016-09-15 B Purchase Redmile Group, LLC Large shareholder
28,000 +0.1%
3.50
US$98,000 		28,000 +0.1% 3.50 US$98,000
2016-09-16 2016-09-15 S Sale Redmile Group, LLC Large shareholder
7,300 -0.0%
3.54
US$25,842 		7,300 -0.0% 3.54 US$25,842
2016-09-16 2016-09-14 B Purchase Redmile Group, LLC Large shareholder
372,000 +2.0%
3.51
US$1,305,720 		372,000 +2.0% 3.51 US$1,305,720
2016-09-16 2016-09-14 S Sale Redmile Group, LLC Large shareholder
392,700 -2.1%
3.50
US$1,374,450 		392,700 -2.1% 3.50 US$1,374,450
2016-01-22 2016-01-20 B Purchase Redmile Group, LLC Large shareholder
300,000 +1.6%
3.19
US$957,000 		300,000 +1.6% 3.19 US$957,000
2016-01-14 2016-01-12 B Purchase Redmile Group, LLC Large shareholder
75,000 +0.4%
3.60
US$270,000 		75,000 +0.4% 3.60 US$270,000
2016-01-11 2016-01-11 B Purchase Redmile Group, LLC Large shareholder
275,000 +1.5%
3.54
US$973,500 		275,000 +1.5% 3.54 US$973,500
2016-01-11 2016-01-08 B Purchase Redmile Group, LLC Large shareholder
350,000 +1.9%
3.72
US$1,302,000 		350,000 +1.9% 3.72 US$1,302,000
2016-01-11 2016-01-07 B Purchase Redmile Group, LLC Large shareholder
300,000 +1.7%
3.73
US$1,119,000 		300,000 +1.7% 3.73 US$1,119,000
2015-10-01 2015-10-01 B Purchase Redmile Group, LLC Large shareholder
100,140 +0.6%
4.50
US$450,630 		100,140 +0.6% 4.50 US$450,630
2015-10-01 2015-09-30 B Purchase Redmile Group, LLC Large shareholder
182,452 +1.0%
4.67
US$852,051 		182,452 +1.0% 4.67 US$852,051
2015-10-01 2015-09-29 B Purchase Redmile Group, LLC Large shareholder
500,000 +2.9%
4.56
US$2,280,000 		500,000 +2.9% 4.56 US$2,280,000
2015-08-28 2015-08-26 B Purchase Redmile Group, LLC Large shareholder
49,900 +0.3%
5.48
US$273,452 		49,900 +0.3% 5.48 US$273,452
2015-08-25 2015-08-25 B Purchase Redmile Group, LLC Large shareholder
220,000 +1.3%
5.45
US$1,199,000 		220,000 +1.3% 5.45 US$1,199,000
2015-08-25 2015-08-24 B Purchase Redmile Group, LLC Large shareholder
410,000 +2.5%
5.32
US$2,181,200 		410,000 +2.5% 5.32 US$2,181,200
2015-08-25 2015-08-21 B Purchase Redmile Group, LLC Large shareholder
160,000 +1.0%
5.45
US$872,000 		160,000 +1.0% 5.45 US$872,000
2015-08-13 2015-08-12 B Purchase Redmile Group, LLC Large shareholder
205,000 +1.3%
5.93
US$1,215,650 		205,000 +1.3% 5.93 US$1,215,650
2015-08-13 2015-08-11 B Purchase Redmile Group, LLC Large shareholder
327,500 +2.1%
5.85
US$1,915,875 		327,500 +2.1% 5.85 US$1,915,875
2015-08-10 2015-08-10 B Purchase Redmile Group, LLC Large shareholder
180,000 +1.1%
5.81
US$1,045,800 		180,000 +1.1% 5.81 US$1,045,800
Explore more

More insider trading research around Array BioPharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America